New therapies in the treatment of overactive bladder

Author： Yeo Eu Kiang Sharon   Hashim Hashim   Abrams Paul  

Publisher： Informa Healthcare

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.18, Iss.3, 2013-09, pp. : 319-337

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transdermal oxybutynin: a new treatment for overactive bladder

By Davila G Willy  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 12, 2003-12 ,pp. : 2315-2324

Informa Healthcare

Access to resources Recommend Favorite

Tolterodine for the treatment of overactive bladder

By Salvatore Stefano   Serati Maurizio   Bolis Pierfrancesco  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 7, 2008-05 ,pp. : 1249-1255

Informa Healthcare

Access to resources Recommend Favorite

Imidafenacin for the treatment of overactive bladder

By Leone Roberti Maggiore Umberto   Scala Carolina   Venturini Pier Luigi   Ferrero Simone  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 10, 2013-07 ,pp. : 1383-1397

Informa Healthcare

Access to resources Recommend Favorite

Mirabegron in the treatment of overactive bladder

By Leone Roberti Maggiore Umberto   Cardozo Linda   Ferrero Simone   Sileo Filomena   Cola Alice   Torella Marco   Colacurci Nicola   Candiani Massimo   Salvatore Stefano  

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 6, 2014-04 ,pp. : 873-887

Informa Healthcare

Access to resources Recommend Favorite

Darifenacin: In the Treatment of Overactive Bladder

By Katherine F. Croom   Gillian M. Keating  

Drugs & Aging, Vol. 21, Iss. 13, 2004-01 ,pp. : 885-892

Adis International

Access to resources Recommend Favorite